Buy ACMR now because the primary trend is bullish (bullish MA stack + expanding positive MACD) and options positioning leans risk-on.
Near-term setup is somewhat stretched (RSI 80) and price is close to resistance (62.35), but for an impatient buyer the momentum backdrop still favors initiating rather than waiting.
Biggest offsetting risk is the sharp acceleration in insider selling; still, fundamentals show strong top-line growth and the tape/derivatives data remain constructive.
Momentum: MACD histogram +0.525 and expanding выше 0 → bullish momentum is strengthening.
Overbought/extension: RSI_6 = 79.8 (typically overbought). This raises the odds of a brief pullback or consolidation, but does not negate the uptrend.
Levels: Pivot 56.11 is the key trend/“line in the sand.” Immediate resistance R1 = 62.35 (current ~61.3); a push/hold above ~62.35 would confirm continuation toward R2 ~66.21.
Short-horizon statistical read: Pattern analog suggests ~+1.76% next day (50% hit-rate) and ~+5.57% over the next week—supports buying into strength rather than waiting for a perfect dip.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Put/Call ratios are low (OI PCR 0.74; Volume PCR 0.18) → positioning skews bullish (calls outweigh puts, especially in volume).
Activity: Today’s option volume 1,297 is ~73.6% of 30D average → not a “panic” chase; more like steady bullish participation.
Volatility: IV_30d ~72.8 vs HV ~90.3; IV percentile ~72.8 (elevated). Options are relatively expensive vs calmer regimes, implying the market is pricing meaningful movement.
Skew/positioning takeaway: Bullish bias, but elevated IV implies better reward/risk for defined-risk structures; directionally it still supports upside near-term.
No analyst rating/price target change data was provided in the dataset, so a verified trend in upgrades/downgrades or target revisions cannot be confirmed here.
Wall Street-style balance (based on available fundamentals/price action only): Pros—strong revenue/EPS growth and bullish trend; Cons—margin compression and heavy insider selling.
Wall Street analysts forecast ACMR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACMR is 41.8 USD with a low forecast of 36 USD and a high forecast of 45 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast ACMR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACMR is 41.8 USD with a low forecast of 36 USD and a high forecast of 45 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 54.390
Low
36
Averages
41.8
High
45
Current: 54.390
Low
36
Averages
41.8
High
45
Roth Capital
Suji Desilva
Buy
downgrade
$50 -> $40
AI Analysis
2025-11-05
Reason
Roth Capital
Suji Desilva
Price Target
$50 -> $40
AI Analysis
2025-11-05
downgrade
Buy
Reason
Roth Capital analyst Suji Desilva lowered the firm's price target on ACM Research to $40 from $50 and keeps a Buy rating on the shares. The company reported a Q3 recovery on a continued demand ramp, the analyst tells investors in a research note. Roth expects ACM's near-term margin headwinds to be temporary but reduced estimates post the Q3 report.
Roth Capital
Buy
maintain
$40 -> $50
2025-09-29
Reason
Roth Capital
Price Target
$40 -> $50
2025-09-29
maintain
Buy
Reason
Roth Capital raised the firm's price target on ACM Research to $50 from $40 and keeps a Buy rating on the shares. ACM Research released its annual backlog update indicating strong year over year growth, and Roth is encouraged by continued demand momentum indicating continued healthy China semiconductor manufacturing demand, the analyst tells investors in a research note. The firm says it is increasingly comfortable with its forecast of mid- to high-teens y/y revenue growth in the next few quarters.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ACMR
